4.5 Article

Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus

Kate M. Bubar et al.

Summary: The study found that prioritizing the vaccine for adults aged 20 to 49 can minimize the number of cases, while prioritizing the vaccine for adults over 60 can minimize mortality and years of life lost. Redirecting vaccine doses to seronegative individuals through individual-level serological tests can improve the impact of each dose.

SCIENCE (2021)

Article Multidisciplinary Sciences

Vaccine optimization for COVID-19: Who to vaccinate first?

Laura Matrajt et al.

Summary: Vaccines are expected to be the best tool for controlling the COVID-19 pandemic, with high effectiveness paired with high coverage able to significantly mitigate the pandemic. Vaccine allocation strategies may vary based on vaccine effectiveness, with high-risk age groups prioritized for low effectiveness vaccines, and high-transmission age groups prioritized for high effectiveness vaccines.

SCIENCE ADVANCES (2021)

Editorial Material Medicine, General & Internal

Priorities for the US Health Community Responding to COVID-19

Amesh A. Adalja et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK

Christopher I. Jarvis et al.

BMC MEDICINE (2020)

Article Infectious Diseases

Assessing the effects of metropolitan-wide quarantine on the spread of COVID-19 in public space and households

Mingwang Shen et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Editorial Material Medicine, General & Internal

The Equitable Distribution of COVID-19 Therapeutics and Vaccines

Thomas J. Bollyky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Multidisciplinary Sciences

A strategic approach to COVID-19 vaccine R&D

Lawrence Corey et al.

SCIENCE (2020)

Article Public, Environmental & Occupational Health

Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention

Sarah M. Bartsch et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2020)

Article Medicine, General & Internal

Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020

Daniel M. Weinberger et al.

JAMA INTERNAL MEDICINE (2020)

Article Medicine, General & Internal

Attitudes Toward a Potential SARS-CoV-2 Vaccine A Survey of US Adults

Kimberly A. Fisher et al.

ANNALS OF INTERNAL MEDICINE (2020)

Article Biochemistry & Molecular Biology

Disease and healthcare burden of COVID-19 in the United States

Ian F. Miller et al.

NATURE MEDICINE (2020)

Editorial Material Medicine, General & Internal

Partitioning the Curve - Interstate Travel Restrictions During the Covid-19 Pandemic

David M. Studdert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Can self-imposed prevention measures mitigate the COVID-19 epidemic?

Lei Zhang et al.

PLOS MEDICINE (2020)

Editorial Material Medicine, General & Internal

Fairly Prioritizing Groups for Access to COVID-19 Vaccines

Govind Persad et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Medicine, General & Internal

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

Gregory A. Poland et al.

LANCET (2020)

Article Mathematical & Computational Biology

Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.?

Enahoro A. Iboi et al.

INFECTIOUS DISEASE MODELLING (2020)